Yahoo
Jakarta - Delayed Quote IDR

PT Sarana Meditama Metropolitan Tbk (SAME.JK)

236.00 -14.00 (-5.60%)
At close: 4:00:03 PM GMT+7
Chart Range Bar
Loading chart for SAME.JK
  • Previous Close 250.00
  • Open 250.00
  • Bid 236.00 x --
  • Ask 238.00 x --
  • Day's Range 236.00 - 250.00
  • 52 Week Range 224.00 - 444.00
  • Volume 148,100
  • Avg. Volume 920,174
  • Market Cap (intraday) 4.051T
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 236.00
  • EPS (TTM) 1.00
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date May 18, 2018
  • 1y Target Est --

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

www.emc.id

3,007

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

SAME.JK
34.81%
IDX COMPOSITE (^JKSE)
43.28%

1-Year Return

SAME.JK
21.33%
IDX COMPOSITE (^JKSE)
40.73%

3-Year Return

SAME.JK
28.48%
IDX COMPOSITE (^JKSE)
27.76%

5-Year Return

SAME.JK
47.32%
IDX COMPOSITE (^JKSE)
25.15%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.85%

  • Return on Assets (ttm)

    1.14%

  • Return on Equity (ttm)

    0.63%

  • Revenue (ttm)

    2.03T

  • Net Income Avi to Common (ttm)

    17.2B

  • Diluted EPS (ttm)

    1.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    175.49B

  • Total Debt/Equity (mrq)

    30.78%

  • Levered Free Cash Flow (ttm)

    97.26B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: